Powdered Cellulose

Summary

Powdered Cellulose (CHEMBL4297924) is a phase-3 clinical-stage unknown; indicated across 5 conditions including osteoarthritis and peripheral arterial disease.

At a glance

• Status: Max clinical phase 3 (not approved)
• Modality: Unknown
• Indications: 5 conditions
• Clinical trials: 95

Identifiers

Drug identity and classification

Field	Value
ChEMBL ID	CHEMBL4297924
Name	Powdered Cellulose
Type	Unknown
Max phase	3

Also known as: Cellulose, Cellulose powder, powdered, E-460(II), INS NO.460(II), INS-460(II), Paper, Powdered cellulose, POWDERED CELLULOSE

Targets

Targets

No target linkage available.

Bioactivity

No ChEMBL bioactivity rows at pChembl ≥ 5 (expected for biologics / antibodies).

Target pathways

No target-pathway data for this drug (no mapped target genes).

Indications & clinical

Indications

5 indications (0 at ChEMBL trial phase 4). Phase below is the highest clinical-trial phase recorded for this drug against each disease — not the molecule’s overall approval status (that is in the Summary).

Indication	Trial phase	MONDO	EFO
osteoarthritis	3	MONDO:0005178	MONDO:0005178
peripheral arterial disease	2	MONDO:0005386	EFO:0004265
sarcoidosis	2	MONDO:0019338	MONDO:0019338
gestational diabetes	0	MONDO:0005406	EFO:0004593

1 further indication record had no mapped disease name (EFO/MeSH-only) or were duplicates, and are omitted.

Clinical trials

Total trials: 95.

Phase distribution

Phase	Trials
Not specified	77
PHASE2	9
PHASE3	5
PHASE1	2
PHASE4	1
PHASE2/PHASE3	1

Top trials by phase / activity

NCT	Phase	Status	Title
NCT06798571	PHASE4	RECRUITING	Role of Menopause in Thermoregulation
NCT00120770	PHASE3	TERMINATED	Cellulose Sulfate (CS) Gel and HIV in Nigeria
NCT00153777	PHASE3	TERMINATED	Cellulose Sulfate and HIV Transmission Among Women
NCT00758082	PHASE3	COMPLETED	Reinforcement of the Impact of a Functional Insulin Therapy Training Course by Telemonotoring With a PDA-phone in Type 1 Diabetic Patients. The TELFIT Study Patients
NCT01148043	PHASE3	COMPLETED	Pharmacological Treatment In Osteoarthritis
NCT01773967	PHASE2/PHASE3	COMPLETED	Impact of Emergency Department Probiotic (LGG) Treatment of Pediatric Gastroenteritis
NCT03605875	PHASE3	COMPLETED	A Web Application for Improving Communication on Hemodialysis Rounds
NCT00255294	PHASE2	COMPLETED	Contraceptive Effectiveness Trial of Cellulose Sulfate Gel
NCT00644098	PHASE2	COMPLETED	Effect of a Soluble Fibre Blend and Medium Chain Triglycerides on Body Composition and Cardiometabolic Risk Factors
NCT02088983	PHASE2	UNKNOWN	Effects of CDP-Choline on Gating and Cognitive Deficits in First Episode Schizophrenia
NCT02117661	PHASE2	COMPLETED	Carnitine for the Treatment of Atherosclerosis.
NCT02123121	PHASE2	COMPLETED	Resveratrol to Enhance Vitality and Vigor in Elders
NCT03477916	PHASE2	COMPLETED	Fecal Microbial Transplantation and Fiber Supplementation in Participants With Obesity and Metabolic Syndrome.
NCT03727321	PHASE2	COMPLETED	FMT and Fiber in Patients With Metabolic Syndrome
NCT04471792	PHASE2	COMPLETED	Creatine Use and Muscle Stretching in Peripheral Artery Disease
NCT05910554	PHASE2	WITHDRAWN	Investigation of the Efficacy of Metformin Therapy on Pulmonary Sarcoidosis
NCT01120808	PHASE1	COMPLETED	Prevention Trial Assessing Paper-Tape in Endurance Distances (PreTAPED)
NCT05478278	PHASE1	COMPLETED	An Evaluation of Psilocybin’s Effect on Cardiac Repolarization and the Effect of Food on Psilocybin’s Pharmacokinetics
NCT05683002	Not specified	ACTIVE_NOT_RECRUITING	Aronia, Cognition, and Eye Health (ACE)
NCT05924646	Not specified	RECRUITING	CAlgary SAlt for POTS
NCT06464952	Not specified	RECRUITING	Microbiome Modulation With Prebiotics in PTSD and Cirrhosis
NCT06529016	Not specified	RECRUITING	Using Dichoptic Therapy to Treat Intermittent Exotropia
NCT06548048	Not specified	RECRUITING	Dietary Supplementation on Fat Oxidation
NCT07329452	Not specified	RECRUITING	Menu to Meal (M2M) Menu Labeling Intervention Study
NCT07525180	Not specified	NOT_YET_RECRUITING	Comparing Prebiotic Fiber Supplements for Gut Health and Digestive Comfort
NCT07587424	Not specified	NOT_YET_RECRUITING	Impact of Dietary Fibre Supplementation on Gut Symptoms in Healthy Participants
NCT00122395	Not specified	COMPLETED	Trial Regarding the Acceptability of Audiotape Intimate Partner Violence (IPV) Screening
NCT00750438	Not specified	COMPLETED	Effect of Fibre Products on Appetite and Weight
NCT00849004	Not specified	UNKNOWN	Prevention of Hypertrophic Scars or Keloids
NCT00904124	Not specified	COMPLETED	The Effect of Different Types of Dietary Fiber on Satiation
NCT00919932	Not specified	COMPLETED	Using a Text-message System to Engage Depressed Adolescents in Cognitive-behavioral Therapy Homework
NCT00951639	Not specified	COMPLETED	Cassia Cinnamon for Glucose Uptake in Young Women
NCT01008241	Not specified	COMPLETED	South Florida Residents Knowledge and Opinions on End-of-Life Issues
NCT01134588	Not specified	COMPLETED	Assessment of Quality of Life in Disorders of the Pelvic Floor
NCT01296945	Not specified	COMPLETED	Nutrition Knowledge for Spanish-speaking Parents
NCT01399073	Not specified	COMPLETED	Virtual Reality for Neglect Diagnostics
NCT01596907	Not specified	COMPLETED	Treatment of Low Metabolic Rate Following Bariatric Surgery
NCT01831492	Not specified	COMPLETED	Effects of Zeolite + Dolomite on Performance and Acidosis
NCT01841073	Not specified	COMPLETED	Effect of Fermentable Carbohydrate on Glucose Homeostasis
NCT01945112	Not specified	COMPLETED	Prevention Trial Assessing Paper-Tape in Endurance Distances II (Pre-TAPED II)

Clinical evidence (CIViC)

No CIViC predictive evidence (expected for non-precision-medicine drugs).

Pharmacology

Pharmacogenomics

No PharmGKB pharmacogenomic data curated for this drug.

Related molecules

Related molecules

No competitor molecules sharing a primary target (ChEMBL phase ≥2 or PubChem drug-class).